Zogenix reported $33.88M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.79M 14.87M
Acura Pharmaceuticals ACUR:US 523K 138K
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Aerie Pharmaceuticals AERI:US $ 34.54M 1.94M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Antares Pharma ATRS:US $ 17.7M 97K
Arena Pharmaceuticals ARNA:US $ 31.94M 2.48M
AstraZeneca AZN:LN 2.57B 76M
Becton, Dickinson and BDX:US $ 1.24B 89M
Biocryst Pharmaceuticals BCRX:US $ 26.32M 4.21M
Biogen BIIB:US $ 637.3M 42.3M
Cardinal Health CAH:US 1.13B 9M
Esperion Therapeutics ESPR:US $ 46.32M 14.75M
Flexion Therapeutics FLXN:US $ 27.41M 189K
GlaxoSmithKline GSK:LN 2.5B 183M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Heron Therapeutics HRTX:US $ 33.16M 8.35M
Intra Cellular Therapies ITCI:US $ 69.85M 17.27M
Johnson & Johnson JNJ:US $ 6.07B 641M
Marinus Pharmaceuticals MRNS:US 6.83M 3.55M
Merk MRK:US $ 2.25B 376M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Pfizer PFE:US $ 2.79B 134M
Revance Therapeutics RVNC:US $ 49.01M 937K
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Teva Pharmaceutical TEVA:IT 832M 16M
Zogenix ZGNX:US $ 33.88M 2.61M